Clinical Trial Update: NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients. [Phase 4]

View source ↗

Summary

A Phase 4 study investigating relationships between clinical, biological, and pharmacokinetic metrics and toxicities in ovarian cancer patients treated with nir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer
• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer | Phase 4 | Status: TERMINATED